Luxna Biotech & Inabata ink license agreement for manufacture and sale of modified nucleic acid GuNA amidite: Osaka, Japan Monday, March 16, 2026, 09:00 Hrs [IST] Luxna Biotech Co ...
Under the terms of the agreement, Codexis will produce siRNA material to support its partner's preclinical program. The ...
Students have been able to continue research that could offer novel treatment for ovarian and prostate cancers, resilience ...
Codexis inks agreement with an innovator pharma company to manufacture 50 grams siRNA using its ECO Synthesis platform: Redwood City, California Friday, March 6, 2026, 11:00 Hrs [ ...
A remarkably small bacterium containing fewer than 500 genes serves as the basis for one of the most detailed digital life ...
Christine Dunham is a leading expert on the ribosome—an elaborate macro-molecular machine that operates like a factory within ...
Pritelivir, an investigational antiviral for herpes simplex virus, demonstrated strong efficacy in a phase 3 trial, with 62.7 ...
14d
4basebio strengthens commercial leadership, promoting Christine Wolosin to Chief Commercial Officer
Seasoned biotechnology commercial leader will drive global growth strategy Commercial team further bolstered by promotions of James Vang and ...
A resurfaced CIA document reveals that US intelligence once examined research hinting at a potential cancer treatment more ...
The lipid nanoparticles market growth is driven by rising demand for advanced drug delivery systems, increasing adoption of ...
In this interview, Professor Anne Willis discusses her research on posttranscriptional control of gene expression and shares ...
Extracellular vesicles (EVs) are tiny biological bubbles that carry nucleic acids and proteins between cells, playing an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results